InvestorsHub Logo
Followers 21
Posts 1095
Boards Moderated 0
Alias Born 01/28/2014

Re: Abundance88 post# 34361

Thursday, 01/25/2024 12:44:32 PM

Thursday, January 25, 2024 12:44:32 PM

Post# of 34588
Seems like Bunka is having time to go through board messages , can he then also address the failures. The whole Japan co deal worth 4.5 mil would have sponsored some of the R&D expense, but having little to no revenue even after all these years of proving how "DHT" is better than what they are using now does not add much to the confidence of existing shareholders.

Nicotine pouch / Tobacco industry is bigger than Diabetes/Hypertension combined, still with very positive results, not a single taker on anything to do with DHT.
How come Bumka is not able to explain these gaps that I can clearly see between vision and its execution in this shareholder letter.

The failures have not been explained to give enough confidence whether the newer initiatives will yield any +ve results.

There are small biotech's that have gone up 30x like TPST, KALA or ALT etc, especially knowing that DHT is better than the one Novo got for 1.8 bil, not sure why its competitors are not pursuing joint trails using DHT

With such low mcap, for companies that big and having to sponsor these planned trials is chump change of few mil 5-10mil and acquire 25-30% of Lexx biotech subsidiary. That's what is baffling ,why none of the big ones are approaching Bumka
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News